AbbVie Inc. (NYSE:ABBV) Position Lessened by Guardian Investment Management
Guardian Investment Management reduced its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 7.5% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 18,251 shares of the company’s stock after selling 1,475 shares during the period. AbbVie accounts for approximately 2.9% of Guardian Investment Management’s holdings, making the stock its 8th biggest […]
Bright Financial Advisors Inc. Makes New Investment in AbbVie Inc. (NYSE:ABBV)
Bright Financial Advisors Inc. acquired a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,040 shares of the company’s stock, valued at approximately $205,000. Other large investors have also recently modified their holdings of the […]
AbbVie Inc. (NYSE:ABBV) Stock Holdings Lessened by Patriot Investment Management Group Inc.
Patriot Investment Management Group Inc. cut its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 9.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,386 shares of the company’s stock after selling 535 shares during the […]
Procyon Advisors LLC Reduces Position in AbbVie Inc. (NYSE:ABBV)
Procyon Advisors LLC trimmed its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 4.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 27,647 shares of the company’s stock after selling 1,227 shares during the quarter. Procyon Advisors LLC’s holdings in AbbVie […]
ORG Wealth Partners LLC Makes New $2.57 Million Investment in AbbVie Inc. (NYSE:ABBV)
ORG Wealth Partners LLC bought a new position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 12,996 shares of the company’s stock, valued at approximately $2,567,000. AbbVie accounts for approximately 1.0% of ORG Wealth Partners […]
last updated on 15 Oct 01:14